Methotrexate Sodium Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Mar 13, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-3678-01
Dosage Form
Injection
Presentation
Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)
Initial Posting
Mar 13, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.